Neudle.com: dystonia parkinsonism

Differential
(Click to cross reference)

aciduria

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome-related complex

adolescent medicine

advances in neurology

adverse drug reaction

agitation

akathisia

akinesia of eyelid function

alcohol

algorithm

alien hand syndrome

alternating hemiplegia

alternating hemiplegia of childhood

anti basal ganglia antibodies

anti IgLON5

anticholinergic drugs

aphasia

aphasia, progressive, primary

aphonia

applause sign

apraxia

apraxia of eye movements

apraxia of eyelid opening

apraxia, constructional

attention deficit disorder with hyperactivity

atypical

autoantibodies

autoimmune basal ganglia encephalitis

autoimmune disease

autonomic dysfunction

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

benign essential tremor

bent spine syndrome

beta adrenergic blocker

calcification, intracranial

calcium antagonist

calcium antagonist, side effects of

calculations

camptocormia

carbamazepine

carbon monoxide poisoning

CAT scan

CAT scan, abnormal

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, isodense lesion with acute hemorrhage

CAT scan, muscle

catecholamine

central hypoventilation

central nervous system, infection of

cerebral cortical atrophy

cerebral ischemia

cerebral palsy

cerebral vasculature, calcification

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrovascular accident

cerebrovascular accident, complications with

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

comprehension, impaired

compression fracture

conjugate gaze, forced

consanguinity

contractures, joint

convergence, impaired

conversion reaction

copper metabolism, abnormal

cortical-basal ganglionic degeneration

creatine phosphokinase(CPK)elevated

crying, pathologic

cultured skin fibroblasts

cyanide poison

deep gray nuclei

degenerative diseases of CNS

delay in diagnosis

dementia

depression

developmental milestones, loss of

developmental retardation

dexterity, impaired

diagnostic criteria

differential diagnosis

diplopia

disability, neurological

diurnal variation

dopa responsive dystonia

drug induced neurologic disorders

drug withdrawal

dysarthria

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, causes of

dyskinesia, drug induced

dystonia musculorum deformens

dystonia, axial

dystonia, cervical

dystonia, children

dystonia, classification

dystonia, delayed onset

dystonia, drug induced

dystonia, etiology of

dystonia, evaluation of

dystonia, face

dystonia, focal

dystonia, painful

dystonia, post traumatic

dystonia, psychogenic

dystonia, treatment of

dystonic reaction, acute

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, viral

encephalopathy

encephalopathy, progressive

enzyme, defect

epidemiology of neurology

equinovarus

exercise

exercise-induced neurologic dysfunction

extrapyramidal

extrapyramidal movement disorder, progressive

eye movement, disorders of

facial appearance, abnormal

facial expression abnormality

Fahr disease

falling

familial

fine motor function, impaired

flunarizine

fluoxetine

foot deformity

frontal behavioral spatial syndrome

frontal lobe, atrophy

gait disorder

gait, apraxic

galactorrhea

gamma amino butyric acid

gangliosidosis GM1

gaze palsy

gaze palsy, supranuclear

genetic diagnosis, prenatal

genetic neurologic disorders

genetic testing

gests antagoniste

Gilles de la Tourette syndrome

glabellar sign

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

GLUT1 deficiency syndrome

grasp reflex

grimacing

Hallervorden Spatz disease

Hallervorden Spatz disease, late onset

hallucination, visual

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatic failure

hepatolenticular degeneration(Wilson's disease)

hepatosplenomegaly

heralding manifestation

HLA

hoarseness

homovanillic acid

human immunodeficiency virus type 1

iatrogenic neurologic disorders

inborn errors of metabolism

inclusion bodies, intranuclear

intellectual deterioration

intracerebral hemorrhage

iron, brain

Jakob-Creutzfeldt disease

jaw jerk, abnormal

Kayser-Fleischer ring

kyphosis

language disorder in adults

laughing, pathologic

L-dopa

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

Lewy body disease, diffuse

lipid storage disorder of CNS

manganese intoxication

masked facies

medical-legal aspects of neurology

memory, defect of recent

memory, impairment of

meningitis

meningitis, carcinomatous

mental status, abnormal

metabolic disorder, primary

mitochondrial disease

movement disorder, delayed onset

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, hyperkinetic

movement disorder, psychogenic

movement disorder, treatment of

MRI

MRI pattern

MRI, abnormal

MRI, CAT scan compared to

MRI, diffusion weighted

MRI, eye of tiger sign

MRI, gradient-echo

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, mouse ears

MRI, negative

MRI, paramagnetic effect

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple sclerosis

multiple system atrophy

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurochemistry

neurodegeneration with brain iron accumulation

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic disease, diagnoses of, clinical bedside

neurologic disease, tempo

neurologic signs

neurologic symptoms

neuronal intranuclear inclusion disease

next-generation sequencing

Niemann-Pick disease

nonsteroidal anti-inflammatory drug

norepinephrine

nystagmus

nystagmus, monocular

obsessive-compulsive disorder

ocular motility, disorders of

ocular myopathy

ocular myopathy, differential diagnosis

oculogyric crisis

old age, neurology of

opened mouth

ophthalmoplegia

optic atrophy

optokinetic nystagmus, abnormal

paraplegia, in flexion

parasomnia

paraspinal muscle

paraspinal muscle weakness

Parkinson disease

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, juvenile

Parkinson disease, L-dopa nonresponsive

Parkinson disease, mode of onset

Parkinson disease, on-off phenomena in

Parkinson disease, postencephalitic

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, psychogenic

Parkinson disease, rapid onset

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, young onset

Parkinsonism syndrome

paroxysmal hemiplegia

paroxysmal neurologic deficits

paroxysmal nonkinesigenic dyskinesia

pathologic reflex

patient information and support

penguin silhouette sign

penicillamine

personality change

phenothiazine

phenothiazine, dyskinesia associated with

phenylketonuria

Pick's disease

pigmentary retinopathy

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

POLG1 gene

polycythemia, secondary

pons, lesion of

postural abnormality

precipitating factors

primary familial brain calcification

PRKN gene

procyclidine

prognosis

progressive neurologic disorder

progressive supranuclear palsy

prolactin, elevated

propranolol

pseudobulbar palsy

pseudohypoparathyroidism

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

putamen, lesion of, bilateral

quadriplegia

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

reading problem, causes of

recurrent

Red flags

reflex sympathetic dystrophy

release phenomena

renal failure

repetition, impaired

respirations in CNS disease

restless leg syndrome

reversible neurologic disorder

saccadic eye movements, abnormal

salivation, excessive

scoliosis

seizure

selective serotonin reuptake inhibitors

sensorineural hearing loss

sensory loss

sensory loss, cortical

sensory tricks

sequencing difficulty

short stature

sinemet

single photon emission computed tomography

sleep apnea, obstructive

sleep pathology and physiology

slit lamp examination

somnolence

spastic dysphonia

speech disorder

speech disorder, childhood

stimulation, deep brain

stimulation, thalamic

stooped posture

striatal encephalitis

striopallidodentate calcifications, familial idiopathic

subarachnoid hemorrhage

substantia nigra

suck reflex

swallow evaluation

symmetric brain lesions

tardive dyskinesia

tardive dyskinesia, treatment of

thalamus, lesion of-bilateral

torticollis, post traumatic

toxoplasmosis, CNS

trauma

treatment failure

treatment of neurologic disorder

tremor, post traumatic

tyrosine hydroxylase deficiency

visuospatial disturbance

vocal cord paralysis

walking

walking frame

walking, difficulty with

weakness, progressive

X-linked dystonia-parkinsonism syndrome

Showing articles 500 to 550 of 1676 << Previous Next >>

Pathological Gambling Associated with Dopamine Agonist Therapy in Parkinson's
Neurol 61:422-423, Driver-Dunckley,E.,et al, 2003

Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease
Arch Neurol 60:1059-1064,1043, Chen,H.,et al, 2003

Language Function and Dysfunction in Corticobasal Degeneration
Neurol 61:493-499, Graham,N.L.,et al, 2003

A Double-Blind Controlled Trial of Bilateral Fetal Nigral Transplantation in Parkinson's Disease
Ann Neurol 54:403-414, Olanow,C.W.,et al, 2003

Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003

Awakenings From Persistent Vegetative State: Report of Three Cases With Parkinsonism and Brain Stem Lesions on MRI
JNNP 74:1571-1573, Matsuda,W.,et al, 2003

Five-Year Follow-up of Bilateral Stimulatioin of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 349:1925-1934,1888, Krack,P.,et al, 2003

Orthostatic Hypotension in De Novo Parkinson Disease
Arch Neurol 60:1400-1404, Bonuccelli,U.,et al, 2003

Disappearance of Resting Tremor After "Stereotaxic" Thalamic Stroke
Neurol 61:1014-1015, Probst-Cousin,S.,et al, 2003

A Controlled Trial of Rotigotine Monotherapy in Early Parkinson's Disease
Arch Neurol 60:1721-1728, The Parkinson Study Group, 2003

Treatments of Parkinson Disease
Arch Neurol 60:1680-1684, Shults,C.W., 2003

Long-Term Follow-Up of Thalamic Deep Brain Stimulation for Essential and Parkinsonian Tremor
Neurol 61:1601-1604, Kumar,R.,et al, 2003

Vascular Parkinsonism in Moyamoya: Microvascular Biopsy and Imaging Corrleates
Ann Neurol 54:836-840, Tan,E.,et al, 2003

Dementia with Lewy Bodies
Lancet 362:1689-1690, Wilcock,G.K., 2003

Severe Worsening of Parkinsonism in Lewy Body Dementia Due to Donepezil
Neurol 61:1452, Onofri,M. & Thomas,A., 2003

Encephalitis lethargica syndrome:20 new cases and evidence of basal ganglia autoimmunity
Brain 127, 21-33, Dale, R.C., et al, 2003

Bilateral Subthalamic Nucleus Stimulation Improves Health-Related Quality of Life in PD
Neurol 59:1976-1978, Lagrange,E.,et al, 2002

Treatment Interventions for Parkinson's Disease: An Evidence Based Assessment
Lancet 359:1589-1598, Rascol,O.,et al, 2002

Impact of Sustained Deprenyl (Selegiline) in Levodopa-Treated Parkinson's Disease: A Randomized Placebo-Controlled Extension of the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism Trial
Ann Nuerol 51:604-612, Shoulson,I.,et al, 2002

Cholinergic Vesicular Transporters in Progressive Supranuclesar Palsy
Neurol 58:1013-1018,997, Suzuki,M.,et al, 2002

Botulinum Toxin for Cricopharyngeal Dysfunction in Parkinson's Disease
NEJM 346:1174-1175, Restivo,D.A.,et al, 2002

How Valid is the Clinical Diagnosis of Parkinson's Disease in the Community?
JNNP 73:529-534, Scharg,A.,et al, 2002

Blepharospasm
Neurol 59:1306-1312, Hallett,M., 2002

Ptosis as a Remote Effect of Therapeutic Botulinum Toxin B Injection
Neurol 59:1445-1447, Racette,B.A.,et al, 2002

Effect on Mood of Subthalamic DBS for Parkinson's Disease
Neurol 59:1427-1429, Berney,A.,et al, 2002

Mania Following Deep Brain Stimulation for Parkinson's Disease
Neurol 59:1421-1424, Kulisevsky,J.,et al, 2002

Diagnostic Criteria for Dystonia in DYT1 Families
Neurol 59:1780-1782, Bressman,S.B.,et al, 2002

Driving Safety in Parkinson's Disease
Neurol 59:1787-1788, Zesiewicz,T.A.,et al, 2002

Subthalamic DBS Replaces Levodopa in Parkinson's Disease
Neurol 58:396-401, Vingerhoets,F.J.G.,et al, 2002

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease
JAMA 287:455-463,509, Hobson,D.E.,et al, 2002

Practice Parameter: Initiation of Treatment for Parkinson's Disease: An Evidence-based Review
Neurol 58:11-17, Miyasaki,J.M.,et al, 2002

Cervical Disc Prolapse with Cord Compression Presenting with Choreoathetosis and Dystonia
Neurol 58:661-662, Tan,E.K.,et al, 2002

Diffusion-weighted MRI Differentiates the Parkinson Variant of Multiple System Atrophy from PD
Neurol 58:575-580, Schocke,M.F.H.,et al, 2002

Botulinum Toxin A Treatment for Primary Hemifacial Spasm
Arch Neurol 59:418-420, Defazio,G.,et al, 2002

Donepezil for Cognitive Impairment in Parkinson's Disease: A Randomised Controlled Study
JNNP 72:708-712, Aarsland,D.,et al, 2002

Incidence and Prediction of Falls in Parkinson's Disease: A Prospecitve Multidisciplinary Study
JNNP 72:721-725, Wood,B.H.,et al, 2002

Acute Dystonic Reactions to "Street Xanax"
NEJM 346:1753, Hendrickson,R.G.,et al, 2002

Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002

Nonmotor Fluctuations in Parkinson's Disease
Neurol 59:408-413, Witjas,T.,et al, 2002

Reversible Chorea and Focal Dystonia in Vitamin B12 Deficiency
NEJM 347:295, Pacchetti,C.,et al, 2002

A Meta-Analysis of Coffee Drinking, Cigarette Smoking, and the Risk of Parkinson's Disease
Ann Neurol 52:276-284,261, Hernan,M.A.,et al, 2002

Intakes of Vitamins E and C, Carotenoids, Vitamin Supplements, and PD Risk
Neurol 59:1161-1169, Zhang,S.M.,et al, 2002

T2-weighted MRI Differentiates Multiple System Atrophy from Parkinson's Disease
Neurol 59;1265-1267, Kraft,E.,et al, 2002

Familial Dementia With Lewy Bodies
Arch Neurol 59:1622-1630, Tsuang,D.W.,et al, 2002

Mitochondrial Therapy for Parkinson Disease
Arch Neurol 59:1523, Rosenberg,R.N., 2002

Post-Streptococcal Autoimmune Dystonia With Isolated Bilateral Striatal Necrosis
Dev Med Child Neurol 44:485-489, Dale,R.C.,et al, 2002

Drug-Induced Pisa Syndrome (Pleurothotomus)
CNS Drugs 10:166-174, Suzuki, T. & Matsuzaka, H., 2002

Safety and Efficacy of Pallidal or Subthalamic Nucleus Stimulation in Advanced PD
Neurol 56:548-551, Volkmann,J.,et al, 2001

Deep Brain Stimulation of the Subthalamic Nucleus: Clinical Effectiveness and Safety
Neurol 56:552-554, Lopiano,L.,et al, 2001

Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
NEJM 344:710-719,763, Freed,C.R.,et al, 2001

Showing articles 500 to 550 of 1676 << Previous Next >>